Opportunity

DIBBS #SPE2DP-26-T-3588

DLA Solicitation for Fluticasone Propionate Inhalation Aerosol (GlaxoSmithKline) for Navy Vessel

Posted

June 01, 2026

Respond By

June 08, 2026

Identifier

SPE2DP-26-T-3588

NAICS

424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is seeking quotations for the supply of Fluticasone Propionate Inhalation Aerosol for delivery to a U.S. Navy vessel. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEM Highlight: - GlaxoSmithKline, LLC is the approved source for the requested pharmaceutical - Products Requested: - Fluticasone Propionate Inhalation Aerosol, 220 mcg, 120 metered doses per inhaler - NSN: 6505-01-532-6922 - Part Number: NDC66993-0080-96 - Quantity: 5 units - Must not contain chlorofluorocarbons - Must have at least 15 months remaining shelf life at delivery (18-month total shelf life) - Packaging and labeling must comply with Medical Marking Standard No. 1A - Delivery & Performance: - Delivery required within 5 days of award - Delivery location: USS George Washington (CVN 73), FPO AP 96607 - Notable Requirements: - Fast award process - Strict compliance with federal acquisition and medical supply standards

Description

FLUTICASONE PROPION (QTY: 5, NSN: 6505-01-532-6922, Purchase Request: 7016956120) Approved Sources: - CAGE: 667E9, Part No: NDC66993-0080-96, Company: GLAXOSMITHKLINE, LLC

View original listing